Diana D. Jeffery, PhD, on Mental Health Comorbidities: Predictors of Cost and Utilization
2017 Quality Care SymposiumDiana D. Jeffery, PhD, of the Defense Health Agency, discusses the need to screen for mental health comorbidities, including depression, anxiety, adjustment disorders, substance use disorders, and persistent mental illnesses, as shown in a study of breast and prostate cancer patients (Abstract 18).
Related Videos
Brian Weiss, MD, on Reducing Treatment Errors With Improvement Science
Brian Weiss, MD, of Cincinnati Children’s Hospital Medical Center, discusses a program designed to eliminate errors in chemotherapy use among pediatric patients whose regimens incorpo...
Blase N. Polite, MD, MPP: The Oncology Care Model in Academia
Blase N. Polite, MD, MPP, of the University of Chicago, discusses implementing the Oncology Care Model in an academic health center and the challenges of getting buy-in from faculty m...
Julie Bryar Porter, MS, on Improving Care: One Center’s Experience
Julie Bryar Porter, MS, of Stanford Health Care, discusses an approach to improving patient care with physician-led quality measures from diagnosis through end of life implemented at ...
John V. Cox, DO, MBA, on 2017 Quality Care Symposium Highlights: Expert Perspective
John V. Cox, DO, MBA, of the Parkland Health System/UTSW, discusses some of the key presentations at the 2017 Quality Care Symposium (Abstracts 3, 37, 52).
Laura E. Panattoni, PhD, on Costs of Preventable Emergency Department Use
Laura E. Panattoni, PhD, of the Fred Hutchinson Cancer Research Center, discusses results from a regional study on emergency department costs during cancer treatment and the need to f...
